by Sabrina | Jun 2, 2025 | Uncategorized, Uncategorized
Por Álvaro Brunini, presidente de la Agencia Nacional de Investigación e Innovación*. *Esta columna se publicó en la edición Nª1 de la newsletter de LAB+. Cada edición contará con un/a columnista invitado/a. La ciencia, la tecnología y el conocimiento deben...
by Sabrina | May 28, 2025 | Uncategorized
As Director of LAB+ and the Institut Pasteur de Montevideo, I’m pleased to introduce the very first edition of the LAB+ newsletter — a space created to share our progress, as well as updates from the startups we support and the researchers working within them. We...
by Sabrina | Mar 18, 2024 | Uncategorized
Eolo Pharma, the drug design and development company founded and driven by researchers and entrepreneurs from the Institut Pasteur de Montevideo (IP Montevideo) and the University of the Republic (Udelar), obtained approval to initiate the first human clinical trial...
by admin | Apr 22, 2021 | Uncategorized
(Bloomberg)- By Ken Parks Institute Pasteur Montevideo is launching a $35m venture capital fund to finance startup companies, the institution’s executive director Carlos Batthyany said in a webcast press conference. The fund, Lab+ Venture Builder, will invest...
by admin | Apr 19, 2021 | Uncategorized
Lab + Venture Builder is the name for the initiative promoted by the Institut Pasteur de Montevideo with the financial contribution and know-how of a venture capital fund led by Ficus Advisory. A “Venture Builder” is an internationally recognized type of structure,...
Recent Comments